Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Laura, Negrotto"'
Autor:
Fatima Pagani Cassara, Verónica Tkachuk, María C. Ysrraelit, Patricio Blaya, Santiago Tizio, Andrés Barboza, Alejandro Caride, Matías Kohler, Gustavo Jose, Jimena Miguez, Jorge Blanche, Luciana Lazaro, Cecilia Pita, Liliana Patrucco, María. L. Doldan, Vladimiro Sinay, Guido Vazquez, Lorena M. Cabrera, Gabriel Volman, Judith Steinberg, Felisa Leguizamon, Ruben Manzi, María Laura Menichini, Jorge Correale, Gustavo Sgrilli, Eduardo Knorre, Emanuel Silva, Marcos Burgos, María I. Gaitán, Edgardo Reich, Carlos Vrech, Raúl Piedrabuena, Ivan Martos, Mariano Marrodan, Maria Laura Saladino, Adriana Carrá, Leila Cohen, Juan Pablo Viglione, Amelia Alvez Pinheiro, Norma Deri, Nora Fernández Liguori, Santiago Bestoso, Marina Alonso Serena, Juan Pablo Pettinicchi, Mariano Coppola, Edgardo Cristiano, Ricardo Alonso, Fernando Caceres, Alejandra D. Martinez, Agustín Pappolla, Maria E. Fracaro, Geraldine Luetic, Dario Tavolini, Carolina Mainella, Marcela Parada Marcilla, Laura Negrotto, Luciano Recchia, Juan Ignacio Rojas, María Eugenia Balbuena, Pablo Divi, Orlando Garcea, María Celeste Curbelo, Berenice Silva, Miguel Jacobo, Eduardo Kohler, Gisela Zanga, Edgar Carnero Contentti, Susana Liwacki, Pablo A. López, Marcela Fiol, Diego Giunta, Javier Pablo Hryb, Pedro Nofal
Publikováno v:
Journal of Clinical Neuroscience. 89:360-364
The objectives of the present study were to describe the frequency of aggressive multiple sclerosis (aMS) as well as to compare clinical and radiological characteristics in aMS and non-aMS patients included in RelevarEM (NCT03375177).The eligible stu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::381d2fc6abcef5f96a0be4acffa55fdc
https://doi.org/10.1016/j.jocn.2021.05.047
https://doi.org/10.1016/j.jocn.2021.05.047
Autor:
María Isabel Zuluaga Rodas, Laura Negrotto, Mariana Deramo, Jihad Inshasi, Amir Boshra, Joseph Youssef, Sabrina De Souza, Elisabetta Verdun Di Cantogno, Tahani Boumenna
Publikováno v:
Multiple Sclerosis and Related Disorders. 71:104351
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1b5ad42ee5d771f43c99ad9fbed7633b
https://doi.org/10.1016/j.msard.2022.104351
https://doi.org/10.1016/j.msard.2022.104351
Autor:
Fatima Pagani Cassara, María C. Ysrraelit, Santiago Tizio, Alejandra D. Martinez, Dario Tavolini, Carolina Mainella, Geraldine Luetic, Laura Negrotto, Miguel Jacobo, Edgardo Cristiano, Ricardo Alonso, Liliana Patrucco, Marcela Parada Marcilla, Judith Steinberg, Roberto Rotta Escalante, Berenice Silva, Javier Pablo Hryb, Andrés Barboza, Jimena Miguez, Juan Ignacio Rojas, Santiago Bestoso, Norma Deri, Pablo López, Susana Liwacki, Vladimiro Sinay, Gisela Zanga, Lorena M. Cabrera, María Laura Menichini, Edgar Carnero Contentti, Carlos Vrech, Raúl Piedrabuena, Celia Pérez, María I. Gaitán, Verónica Tkachuk
Publikováno v:
Neurología Argentina. 13:24-36
Resumen Introduccion La esclerosis multiple es una enfermedad con componente autoinmune, y un numero significativo de pacientes se encuentra bajo tratamiento inmunomodulador e inmunosupresor. Frecuentemente los medicos tratantes se preguntan si la va
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f880a67b26bfa35ffb7e19c24f291385
https://doi.org/10.1016/j.neuarg.2020.09.002
https://doi.org/10.1016/j.neuarg.2020.09.002
Autor:
James Landefeld, Patrick Barba, Rob Knight, Zongqi Xia, Patrizia Casaccia, Stephen L. Hauser, Siddharthan Chandran, Stacy J. Caillier, Xiaoming Jia, Elizabeth Crabtree, Ilana Katz Sand, Amit Bar-Or, Scott S. Zamvil, Reinhard Hohlfeld, David Otaegui, Sergio E. Baranzini, Bruce A.C. Cree, Adam Santaniello, Jorge Correale, Jorge R. Oksenberg, Sneha Singh, Laura Negrotto, Jeffery Gelfand, Mauricio F. Farez, Anne-Katrin Pröbstel, Peter Connick, Gail Ackermann, Greg Humphrey, Howard L. Weiner, Michael R. Wilson, Ryan Baumann, Jennifer Graves, Tanuja Chitnis, Tamara Castillo-Triviño, Xiaoyuan Zhou
Publikováno v:
Mult Scler
Background: Evidence for a role of human gut microbiota in multiple sclerosis (MS) risk is mounting, yet large variability is seen across studies. This is, in part, due to the lack of standardization of study protocols, sample collection methods, and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d7703ea980288ff198a7f7372ee4f579
https://doi.org/10.1177/1352458520924594
https://doi.org/10.1177/1352458520924594
Autor:
Fatima Pagani Cassara, Celeste Curbelo, María C. Ysrraelit, Ivan Martos, Fernando Caceres, Jimena Miguez, Alejandra D. Martinez, Guido Vazquez, Geraldine Luetic, Nora Fernández Liguori, Patricio Blaya, Juan Pablo Pettinicchi, Felisa Leguizamon, Laura Negrotto, Judith Steinberg, Alejandro Caride, Maria E. Fracaro, Carlos Vrech, Raúl Piedrabuena, Vladimiro Sinay, on behalf RelevarEM investigators, Edgardo Reich, Agustín Pappolla, Leila Cohen, Maria Laura Saladino, María Laura Menichini, María Eugenia Balbuena, Adriana Carrá, Andrés Barboza, Santiago Bestoso, Verónica Tkachuk, Gisela Zanga, Cecilia Pita, Luciana Lazaro, Norma Deri, Matías Kohler, Dario Tavolini, Carolina Mainella, Amelia Alvez Pinheiro, Edgar Carnero Contentti, María. L. Doldan, Edgardo Cristiano, Ricardo Alonso, Marina Alonso Serena, Marcos Burgos, Liliana Patrucco, Marcela Parada Marcilla, Santiago Tizio, Gabriel Volman, Mariano Marrodan, Ruben Manzi, Gustavo Jose, Lorena M. Cabrera, Juan Ignacio Rojas, Jorge Correale, Gustavo Sgrilli, María I. Gaitán, Juan Pablo Viglione, Eduardo Knorre, Jorge Blanche, Susana Liwacki, Pablo A. López, Marcela Fiol, Diego Giunta, Berenice Silva, Pablo Divi, Orlando Garcea, Javier Pablo Hryb, Facundo Silveira, Pedro Nofal, Emanuel Silva, Miguel Jacobo, Eduardo Kohler
Publikováno v:
Neurological Sciences. 41:1513-1519
The objective of this study was to describe and compare the baseline epidemiological data of multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD) patients included in RelevarEM (Clinical Trials registry number NCT03375177). Rele
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::20ca816e4ef59f1e538b2005d407ecf3
https://doi.org/10.1007/s10072-019-04230-6
https://doi.org/10.1007/s10072-019-04230-6
Autor:
Patricio Blaya, Alejandro Caride, Celeste Curbelo, María Eugenia Balbuena, Alejandra D. Martinez, María. L. Doldan, Geraldine Luetic, Laura Negrotto, Maria E. Fracaro, Felisa Leguizamon, Amelia Alvez Pinheiro, Gisela Zanga, Eduardo Knorre, Marcos Burgos, Carlos Vrech, Miguel Jacobo, María C. Ysrraelit, Marina Alonso Serena, Susana Liwacki, Liliana Patrucco, Adriana Carrá, Mariano Marrodan, Edgar Carnero Contentti, Jimena Miguez, Marcela Parada Marcilla, Juan Ignacio Rojas, Pablo A. López, Berenice Silva, Marcela Fiol, Nora Fernández Liguori, Javier Pablo Hryb, Leila Cohen, Diego Giunta, Guillermo F. De Lio, Pablo Divi, Jorge Correale, Santiago Bestoso, Verónica Tkachuk, Orlando Garcea, Dario Tavolini, Norma Deri, Carolina Mainella, Facundo Silveira, Judith Steinberg, Pedro Nofal, Emanuel Silva, María I. Gaitán, Edgardo Cristiano, Ricardo Alonso, Andrés Barboza, Juan Pablo Pettinicchi, Guido Vazquez, Santiago Tizio, Lorena M. Cabrera, Gabriel Volman, Ruben Manzi
Publikováno v:
Multiple Sclerosis and Related Disorders. 32:133-137
Despite that different registries already exist in various countries in Europe and North America, no ongoing nationwide registry exists in Latin America (LATAM), a region where the disease behaves differently than in other regions. The objective of t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ee113173511453c393993228f6175d8
https://doi.org/10.1016/j.msard.2019.05.004
https://doi.org/10.1016/j.msard.2019.05.004
Autor:
Liliana Patrucco, Anibal Chertcoff, Deyanira A. Ramirez Navarro, Edgardo Cristiano, Ricardo Alonso, Fatima Pagani Cassara, Juan Ignacio Rojas, Biany Santos Pujols, María C. Ysrraelit, Fernando Hamuy Diaz de Bedoya, Debora Nadur, Lorna Galleguillos Goiry, Verónica Tkachuk, Jimena Miguez, Sebastián Nuñez, Judith Steinberg, Luis C. Rodriguez Salinas, Nicia E. Ramírez Sánchez, Marcos Burgos, Carlos Vrech, Raúl Piedrabuena, Laura Negrotto, Jefferson Becker, Liesbet M. Peeters, Vladimiro Sinay, Aron Benzadon Cohen, Patricio E. Correa Diaz, Orlando Garcea, Pablo A. López, María Laura Menichini, Fernando Gracia, Adriana Tarulla, Luciana Lazaro, Dario Tavolini, Carolina Mainella, Marina Alonso Serena, Adriana Carrá, Berenice Silva, Claudia Cárcamo Rodríguez, Luis A. Garcia Valle, Priscilla Monterrey Alvarez, Geraldine Luetic, Rosalba A. León, Ana M. Toral Granda, Clare Walton, Agustín Pappolla, Geraldine Orozco Escobar, María Eugenia Balbuena, Giordani Rodrigues dos Passos, Roberto Weiser, René Carvajal, Omaira Molina, Norma Deri, Magdalena Casas
Publikováno v:
Multiple Sclerosis and Related Disorders
BACKGROUND: There is no data regarding COVID-19 in Multiple Sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD) patients in Latin America. OBJECTIVE: The objective of this study was to describe the clinical characteristics and outcomes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::344d0a8f16dc7c59d5dfd331e04888c9
https://doi.org/10.1016/j.msard.2021.102886
https://doi.org/10.1016/j.msard.2021.102886
Autor:
Juan Ignacio, Rojas, Marina, Alonso Serena, Orlando, Garcea, Liliana, Patrucco, Adriana, Carrá, Jorge, Correale, Carlos, Vrech, Agustín, Pappolla, Jimena, Miguez, María L, Doldan, Facundo, Silveira, Ricardo, Alonso, Leila, Cohen, Cecilia, Pita, Berenice A, Silva, Marcela, Fiol, María I, Gaitán, Mariano, Marrodan, Laura, Negrotto, María C, Ysrraelit, Norma, Deri, Geraldine, Luetic, Alejandro, Caride, Edgar, Carnero Contentti, Pablo A, Lopez, Juan Pablo, Pettinicchi, Celeste, Curbelo, Alejandra D, Martinez, Judith D, Steinberg, María E, Balbuena, Verónica, Tkachuk, Marcos, Burgos, Eduardo, Knorre, Felisa, Leguizamon, Raúl, Piedrabuena, Susana Del V, Liwacki, Andrés G, Barboza, Pedro, Nofal, Gabriel, Volman, Amelia, Alvez Pinheiro, Javier, Hryb, Dario, Tavolini, Patricio A, Blaya, Emanuel, Silva, Jorge, Blanche, Santiago, Tizio, Fernando, Caceres, María Laura, Saladino, Gisela, Zanga, María E, Fracaro, Gustavo, Sgrilli, Fátima, Pagani Cassara, Guido, Vazquez, Vladimiro, Sinay, María Laura, Menichini, Luciana, Lazaro, Lorena M, Cabrera, Santiago, Bestoso, Pablo, Divi, Miguel, Jacobo, Eduardo, Kohler, Matías, Kohler, Diego, Giunta, Carolina, Mainella, Ruben, Manzi, Marcela, Parada Marcilla, Juan Pablo, Viglione, Ivan, Martos, Edgardo, Reich, Gustavo, Jose, Edgardo, Cristiano, Nora, Fernández Liguori
Publikováno v:
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. 41(6)
The objective of this study was to describe and compare the baseline epidemiological data of multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD) patients included in RelevarEM (Clinical Trials registry number NCT03375177).Relev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::121c9fc1e18b8aeec54ba5eef3d3a641
https://pubmed.ncbi.nlm.nih.gov/31960250
https://pubmed.ncbi.nlm.nih.gov/31960250
Autor:
Emanuel Silva, Geraldine Luetic, Liliana Patrucco, Laura Negrotto, Andrés Barboza, Adriana Carrá, Orlando Garcea, Susana Liwacki, Nora Fernández Liguori, Gisela Zanga, María Eugenia Balbuena, Pablo A. López, Juan Pablo Pettinicchi, Pedro Nofal, Marcela Fiol, Dario Tavolini, Carolina Mainella, Edgar Carnero Contentti, Javier Pablo Hryb, Maria E. Fracaro, Patricio Blaya, Felisa Leguizamon, Juan Ignacio Rojas, Jorge Correale, Alejandro Caride, Luciana Lazaro, María I. Gaitán, María Laura Menichini, Carlos Vrech, Marcos Burgos, Mariano Marrodan, María C. Ysrraelit, Ivan Martos, Jimena Miguez, Verónica Tkachuk, Santiago Bestoso, Amelia Alvez Pinheiro, Marina Alonso Serena, Agustín Pappolla, Norma Deri, Edgardo Cristiano, Ricardo Alonso
Publikováno v:
Multiple Sclerosis and Related Disorders. 49:102742
Background Myelin oligodendrocyte glycoprotein antibodies (MOG-ab) have been described in aquaporin-4-antibodies(AQP4-ab)-negative neuromyelitis optica spectrum disorder (NMOSD) patients. We aimed to evaluate the percentage of AQP4-ab-negative NMOSD
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1eaaa30b0134ff28d005508b1a66a710
https://doi.org/10.1016/j.msard.2021.102742
https://doi.org/10.1016/j.msard.2021.102742
Autor:
Catalina Bensi, Laura Negrotto, Liliana Patrucco, Agustín Pappolla, María I. Gaitán, Edgardo Cristiano, María C. Ysrraelit, M.P. Fiol, J. Correale, Mariano Marrodan, Mauricio F. Farez, Juan Ignacio Rojas
Publikováno v:
Multiple Sclerosis and Related Disorders. 39:101892
Background Although solid information on the natural history of primary progressive multiple sclerosis (PPMS) is available, evidence regarding impact of disease activity on PPMS progression remains controversial. Objective To describe the clinical ch
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::073853b83fdf7413e1d250a6f98f086a
https://doi.org/10.1016/j.msard.2019.101892
https://doi.org/10.1016/j.msard.2019.101892